Caligan Partners’s Verrica Pharmaceuticals VRCA Stock Holding History

Caligan Partners’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.89M	Hold	923,910	–	–	0.35%	23
2025 Q4	$7.68M	Hold	923,910	–	–	0.7%	21
2025 Q3	$3.98M	Sell	923,910 -2	-0%	-$12	0.55%	16
2025 Q2	$4.9M	Buy	923,912 +24,617	+3%	+$132K	0.95%	15
2025 Q1	$3.98M	Buy	899,295 +156,326	+21%	+$1.01M	0.83%	14
2024 Q4	$5.2M	Buy	+742,969	New	+$8.17M	1.32%	13
2023 Q4	–	Sell	-25,959	Closed	-$1.01M	–	12
2023 Q3	$1.01M	Buy	+25,959	New	+$1.32M	0.52%	10

Other funds holding VRCA

Affinity Asset Advisors New York $1.71B AUM 374.45% 1-Year Est. Return

Cannell Capital Alta, Wyoming $154M AUM 40.62% 1-Year Est. Return

Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return